BioSpace News Archive

JW Therapeutics today announced that it has entered into a strategic partnership with MediTrust Health. strengthen cooperation in supplementary m

Regeneron Pharmaceuticals, Inc. announced that the United Kingdom’s Medicines and Healthcare products Regulatory Agency has granted Conditional Marketing Authorization for the casirivimab and imdevimab antibody cocktail, known as REGEN-COV™ in the U.S. and Ronapreve® in the UK and other countries, to prevent and treat acute COVID-19 infection.

Positive high-level results from the PROVENT Phase III pre-exposure prophylaxis trial showed AstraZeneca’s AZD7442 achieved a statistically significant reduction in the incidence of symptomatic COVID-19, the trial’s primary endpoint.

THINK Surgical, Inc., an innovator in the field of orthopedic active robot surgery, is pleased to announce its participation in the American Academy of Orthopaedic Surgeons’ 2021 Annual Meeting, August 31 to September 3 at the San Diego Convention Center.

A novel machine learning based blood testing technology that could help to increase detection of early-stage lung cancer demonstrated promising results in a study published in Nature Communications1.

Regencell Bioscience Holdings Limited today announced that the underwriter of its initial public offering (the “Offering”) had exercised its option to purchase 325,000 additional ordinary shares at the public offering price of US$9.50 per share to cover over-allotments.

Teva Announces Post Hoc Analysis of Long-Term Data Examining Treatment with AUSTEDO ® (deutetrabenazine) Tablets in Adult Patients with Tardive Dyskinesia

Brooklyn ImmunoTherapeutics, Inc . today provided highlights from a Shareholder Update Call conducted by President and Chief Executive Officer Howard J. Federoff, M.D., Ph.D. on August 19, 2021.

Therapeutic Solutions International, Inc., (OTC Markets: TSOI), announced today that Peter C Farrell, PhD, DSc, AM joined the Advisory Board of its Spin-Off Company Campbell Neurosciences.

Palisade Bio, Inc. (Nasdaq: PALI) today announces a new private investment of approximately $5.2 million from the Yuma Regional Medical Center